Download the full report: https://www.reportbuyer.com/product/3833683/?utm_source=PRN GlobalData's Medical Devices sector report, "Dry Powder Inhaler Devices ...

11th November 2014. Boston, MA, USA. DoseOne, LLC holds multiple patents and prepared to partner the most innovative DPIs available today, the DoseOne™ Single Dose Powder Inhaler. Development of the ...

The characteristics of an ideal inhaler are based around the design and formulation of the device, patient use and the clinical effect, together with concordance and patient preference. To ensure ...

Dublin, Oct. 27, 2017 (GLOBE NEWSWIRE) -- The "Dry Powder Inhalers: Products, Therapeutics, Players and Forecasts" report has been added to Research and Markets' offering. Dry Powder Inhalers: ...

The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...

Researchers in the United Kingdom compared the potential impact on carbon footprint and asthma symptom control of switching maintenance therapy to a dry powder inhaler vs continuing with a metered ...

Please provide your email address to receive an email when new articles are posted on . United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of ...

NEW YORK, July 23, 2018 /PRNewswire/ -- Managed care initiatives along with an aging population demographics is propelling growth of the home health care, and fuelling adoption of self-administered ...

Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...

Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use. If you ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization, a ...